Objective To analyze the current situation of research and application of drug regulatory science in EU,and provide suggestions for policy-making of drug regulatory in China.Methods The policy guidelines issued by European Medicines Agency(EMA)and domestic and foreign literature were retrieved to summarize how to carry out drug regulation science in Europe.Results and Conclusion A strategic plan was formulated by the EMA for the implementation of drug regulatory science,and the construction of academic system and discourse system of regulatory science were improved,which played a role in promoting the progress of European drug regulatory science.It is suggested that a phased strategic plan of regulatory science should be established to clarify strategic objectives and main tasks in China as soon as possible.Besides,the construction of discipline system and discourse system should be strengthened to realize the scientific supervision of drugs.
展开▼
机译:Possible Negative Regulatory Effects of Antibiotic Production in a Hetrologous System by Sare_4854, a Novel Member of Streptomyces Antibiotic Regulatory Protein Family (SARP) from a Marine Microorganism Salinispora arenicola CNH643 DSM 44819AU Shu, Xiao Zhang, Wei Yu, Jinlong Wu, Shaowen Ma, Yanling Zhu, Minzhe Xia, Sisi Xia, Shichao Zhang, Hao Li, Aiying (aiyli@126.com) Qi, Chao (qichao@mail.ccnu.edu.cn)
机译:The People's Peking Man: Popular Science and Human Identity in Twentieth-Century China / kexueshetuan zai jindai Zhongguo de mingyun: yi Zhongguokexueshe wei zhongxin科学社团在 近代中国的命运: 以中国科学社为中心(The Science Association and the Change of Society in Modern China: A Study on the Science Society of China)